Nishan M. DeSilva

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Nishan de Silva
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nishan M. DeSilva:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Director Common Stock 11,366 $96,042 $8.45 02 Jan 2026 Direct
Cartesian Therapeutics, Inc. Director Stock Option (Right to Buy) 7,800 $6,162 $0.7900 02 Jan 2026 Direct

Insider Reports Filed by Nishan M. DeSilva

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 16:19
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 16:19
RNAC Cartesian Therapeutics, Inc. 02 Jan 2024 2 $0 4 Director 04 Jan 2024, 17:05
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 3 -$69,750 4 Director 15 Nov 2023, 17:18
RNAC SELECTA BIOSCIENCES INC 02 Jan 2023 1 $0 4 Director 04 Jan 2023, 16:02
RNAC SELECTA BIOSCIENCES INC 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 15:33
RNAC SELECTA BIOSCIENCES INC 02 Dec 2021 1 +$20,723 4 Director 06 Dec 2021, 15:25
RNAC SELECTA BIOSCIENCES INC 23 Jun 2021 1 $0 4 Director 09 Jul 2021, 16:21
RNAC SELECTA BIOSCIENCES INC 23 Jun 2021 0 $0 3 Director 09 Jul 2021, 16:19